Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Groen

Showing results (401-410 of 564) with videos related to

Pageof 57
Sort By:
Ebiomedicine|May 1, 2026
CT-based body composition and its change through time in relation to outcomes in participants screened for lung cancerStijn Bunk, Edwin Bennink, Grigory Sidorenkov, et al.
Cancers|October 6, 2020
An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer PatientsJiacong Wei, Anna A Rybczynska, Pei Meng, et al.
JCO Precision Oncology|July 14, 2022
Cost-Effectiveness of Parallel Versus Sequential Testing of Genetic Aberrations for Stage IV Non-Small-Cell Lung Cancer in the NetherlandsHenri B Wolff, Elisabeth M P Steeghs, Zakile A Mfumbilwa, et al.
Pharmacogenetics and Genomics|May 19, 2005
Genetic variation in the bleomycin hydrolase gene and bleomycin-induced pulmonary toxicity in germ cell cancer patientsJanine Nuver, Martijn F Lutke Holzik, Martine van Zweeden, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 14, 2019
New Fissure-Attached Nodules in Lung Cancer Screening: A Brief Report From The NELSON StudyDaiwei Han, Marjolein A Heuvelmans, Carlijn M van der Aalst, et al.
Frontiers in Endocrinology|December 30, 2022
Case report: TP53 and RB1 loss may facilitate the transformation from lung adenocarcinoma to small cell lung cancer by expressing neuroendocrine markersJun Li, Bing Wei, Junnan Feng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2016
Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2Lucio Crinò, Myung-Ju Ahn, Filippo De Marinis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 2, 2014
Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: possible implications for radiotherapy treatment planning strategiesVikram R Bollineni, Michel J B Koole, Jan Pruim, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON studyJoan E Walter, Marjolein A Heuvelmans, Geertruida H de Bock, et al.
Chest|February 4, 2012
The role of conventional bronchoscopy in the workup of suspicious CT scan screen-detected pulmonary nodulesSusan C van 't Westeinde, Nanda Horeweg, René M Vernhout, et al.
Pageof 57

Showing results (401-410 of 564) with videos related to

Sort By:
Pageof 57
Ebiomedicine|May 1, 2026
CT-based body composition and its change through time in relation to outcomes in participants screened for lung cancerStijn Bunk, Edwin Bennink, Grigory Sidorenkov, et al.
Cancers|October 6, 2020
An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer PatientsJiacong Wei, Anna A Rybczynska, Pei Meng, et al.
JCO Precision Oncology|July 14, 2022
Cost-Effectiveness of Parallel Versus Sequential Testing of Genetic Aberrations for Stage IV Non-Small-Cell Lung Cancer in the NetherlandsHenri B Wolff, Elisabeth M P Steeghs, Zakile A Mfumbilwa, et al.
Pharmacogenetics and Genomics|May 19, 2005
Genetic variation in the bleomycin hydrolase gene and bleomycin-induced pulmonary toxicity in germ cell cancer patientsJanine Nuver, Martijn F Lutke Holzik, Martine van Zweeden, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 14, 2019
New Fissure-Attached Nodules in Lung Cancer Screening: A Brief Report From The NELSON StudyDaiwei Han, Marjolein A Heuvelmans, Carlijn M van der Aalst, et al.
Frontiers in Endocrinology|December 30, 2022
Case report: TP53 and RB1 loss may facilitate the transformation from lung adenocarcinoma to small cell lung cancer by expressing neuroendocrine markersJun Li, Bing Wei, Junnan Feng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2016
Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2Lucio Crinò, Myung-Ju Ahn, Filippo De Marinis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 2, 2014
Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: possible implications for radiotherapy treatment planning strategiesVikram R Bollineni, Michel J B Koole, Jan Pruim, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON studyJoan E Walter, Marjolein A Heuvelmans, Geertruida H de Bock, et al.
Chest|February 4, 2012
The role of conventional bronchoscopy in the workup of suspicious CT scan screen-detected pulmonary nodulesSusan C van 't Westeinde, Nanda Horeweg, René M Vernhout, et al.
Pageof 57